# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0....
Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at Univer...
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used o...
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary b...
Scotiabank analyst Sung Ji Nam maintains Bionano Genomics (NASDAQ:BNGO) with a Sector Outperform and lowers the price target...